- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham
- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma
- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers
WEST PALM BEACH, Fla., June 9, 2026 /PRNewswire/ -- Global Healthcare Accreditation (GHA) is pleased to announce that Uni Hospital, located in Panagyurishte, Bulgaria,...
AscellaHealth Establishes International Strategic Advisory Council, Enhances Global Life Sciences Support Services Amid Regulatory and Market Complexity
EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge SINGAPORE, June 9, 2026 /PRNewswire/ -- Duke-NUS...
Membership reinforces commitment to sustainable growth, regional collaboration, and sovereign digital infrastructure in the NordicsREYKJAVÍK, Iceland, June 9, 2026 /PRNewswire/ -- atNorth, the leading...
Now streaming on Amazon Prime Video in Spain, 'The Pl*nt' combines Ferran Calbet's cinematic direction for HighVideo Films, in collaboration with Royal Queen Seeds. At its centre is what is believed to be Dr. Raphael Mechoulam's final filmed interview, offering a powerful exploration of cannabis science, history and stigma.
GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ -- VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic...